Congenital heart surgery is a specialized surgical discipline dedicated to correcting structural cardiac malformations that develop during fetal cardiac development. The main goals of surgery are to re-establish normal blood circulation pathways, prevent pulmonary hypertension, relieve valve obstructions, and correct abnormal connections between heart chambers or major blood vessels. Depending on the specific defect, treatment may involve complete anatomical repair or palliative staging operations to stabilize cardiac function over time.

Congenital heart surgery is performed under general anesthesia with continuous invasive arterial and central venous monitoring. The surgeon gains access to the heart through a median sternotomy (incision through the chest bone) or a minimally invasive lateral thoracotomy (incision between the ribs). In most procedures, the patient is connected to a cardiopulmonary bypass machine (heart-lung machine), which temporarily takes over cardiac pumping and lung oxygenation functions. Systemic hypothermia (cooling the body) and cardioplegia (medication solution to temporarily stop the heart) are applied to protect heart tissue during repair. The surgeon then closes structural holes with synthetic or pericardial patches, reshapes obstructed heart valves, re-routes abnormal blood vessels, or reconstructs underdeveloped heart chambers. Once the structural repair is complete, the heart is re-warmed, normal cardiac rhythm is restored (sometimes aided by temporary pacing wires), and the patient is gradually removed from cardiopulmonary bypass. The chest is then closed with stainless steel wires, chest tubes are placed to drain fluid, and the patient is transferred to the cardiac intensive care unit.

Surgical intervention for congenital heart disease provides substantial long-term hemodynamic and physical benefits. Successful repairs restore physiologic blood flow patterns, eliminate pathological heart shunts, and normalize pressure within the heart chambers and pulmonary artery. According to the Society of Thoracic Surgeons Congenital Heart Surgery Database (Jacobs et al., 2021), early primary surgical correction significantly reduces long-term mortality, prevents irreversible pulmonary vascular disease, mitigates chronic heart failure symptoms, and allows children to achieve normal growth, developmental milestones, and physical exercise capacity.

Recovery following congenital heart surgery occurs in distinct clinical phases. The immediate postoperative phase takes place in the cardiac intensive care unit over 2 to 7 days, focusing on mechanical ventilation weaning, inotropic support titration, and invasive hemodynamic monitoring. Hospital discharge typically occurs within 7 to 14 days for uncomplicated surgical repairs. Sternal bone healing requires approximately 6 to 8 weeks, during which physical lifting restrictions and sternal precautions must be strictly observed. Long-term clinical recovery extends over several months, supported by routine outpatient echocardiography, exercise testing, and specialized congenital cardiology monitoring.

Congenital heart surgery treats a wide spectrum of structural cardiac defects present at birth. Key indications include septal defects such as ventricular septal defect (a hole between the lower heart chambers) and atrial septal defect (a hole between the upper heart chambers). Surgery also treats complex cyanotic defects, including tetralogy of Fallot (a four-part structural abnormality causing low oxygen), transposition of the great arteries (swapped main cardiac arteries), coarctation of the aorta (narrowing of the main artery), hypoplastic left heart syndrome (underdeveloped left cardiac structures), and truncus arteriosus (a single shared outflow vessel).

Preoperative preparation for congenital heart surgery begins with detailed diagnostic mapping using transthoracic or transesophageal echocardiography, cardiac computed tomography, and cardiac catheterization. The patient undergoes routine blood tests, including complete blood count, blood typing and crossmatching, clotting profiles, and organ function tests. Pediatric and adult patients are screened for active infections and evaluated by a multidisciplinary team including cardiologists, anesthesiologists, and pulmonary specialists. Medication adjustments are made, such as discontinuing blood thinners before elective surgery. Strict fasting guidelines (nothing by mouth) are enforced prior to anesthesia. Families receive structured preoperative education regarding intensive care unit procedures, mechanical ventilation, post-surgical chest tubes, and early physical therapy protocols.

Surgical risks associated with congenital heart surgery vary depending on defect complexity, patient age, and baseline systemic health. Common and mild side effects include surgical site pain, transient post-pericardiotomy fever, mild fluid retention, and temporary nausea. Less common complications include wound infections, delayed sternal healing, postoperative atrial or ventricular arrhythmias requiring temporary pacing or medication, pleural effusions (fluid around lungs), and prolonged mechanical ventilation. Rare but serious risks include severe bleeding requiring reoperation, low cardiac output syndrome, complete heart block requiring a permanent pacemaker, stroke or neurological injury, acute kidney injury necessitating dialysis, persistent pulmonary hypertension, and operative mortality. According to the STS Congenital Heart Surgery Database, overall operative survival across all risk categories exceeds 96%, though high-complexity neonatal procedures carry higher individual risk profiles.

The clinical journey for congenital heart surgery begins with comprehensive diagnostic imaging, including echocardiograms, cardiac magnetic resonance imaging, and cardiac catheterization. Preoperative preparation involves multidisciplinary evaluation by pediatric cardiologists, congenital cardiothoracic surgeons, and cardiac anesthesiologists. The operative phase includes general anesthesia, median sternotomy or thoracotomy, and usually cardiopulmonary bypass support. Following surgery, patients transition to a specialized pediatric or cardiac intensive care unit for advanced monitoring and mechanical support. Long-term recovery includes gradual physical rehabilitation, anti-arrhythmia or hemodynamic medication management, and lifelong outpatient cardiology follow-up.